Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Understanding why young adults struggle with money management is the first step to change. This article outlines common pitfalls and effective strategies to regain control.
24,305 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
June data show manufacturing activity extended its six-month expansion, signaling resilience amid tariffs and inflati...
April retail sales rose 0.5% to $757.1 billion, lifting cash flow for consumer staples stocks. The ETF’s yield remain...
SpaceX’s rapid Nasdaq-100 inclusion could redraw the ETF landscape. This guide explains what changes to expect, how i...
Palantir Technologies and NVIDIA expanded their collaboration to accelerate government-grade AI models, sending Palan...
In 2026, Medicare plans blend zero-premium options with a steep in-network cap, forcing retirees and investors to wei...
Vitalik Buterin unveils a two step plan to shrink Ethereum state and move verification to validators via zero knowled...
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...
HYSA interest is taxed as ordinary income in the year it is credited, not when you spend it. There are no special rat...
The memory-chip rally cools as prices soften and demand slows. This report weighs Micron, SanDisk, and Applied Materi...
Retirees may secure a steadier paycheck by starting small and letting dividend growth drive long‑term income.
Investors fear there is no clean exit from the Iran conflict, leaving Wall Street bracing for volatility as options f...